Collegium Pharmaceutical Inc (COLL)
Payables turnover
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cost of revenue (ttm) | US$ in thousands | 254,105 | 225,559 | 219,450 | 226,700 | 240,598 | 265,314 | 277,090 | 286,555 | 254,445 | 203,309 | 167,865 | 129,383 | 126,251 | 129,535 | 127,788 | 124,779 | 130,180 | 147,289 | 163,060 | 182,020 |
Payables | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Payables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
Payables turnover = Cost of revenue (ttm) ÷ Payables
= $254,105K ÷ $—K
= —
The payables turnover ratio for Collegium Pharmaceutical Inc is not available or not provided in the data provided. The payables turnover ratio is a financial metric that indicates how many times a company pays off its accounts payable during a period. It is calculated by dividing the total purchases by the average accounts payable balance.
Without the specific values for accounts payable and purchases, it is not possible to calculate the payables turnover ratio for the company. However, a higher payables turnover ratio generally indicates that the company is efficiently managing its payables by paying them off quickly, which can be a positive sign of financial health. Conversely, a low payables turnover ratio may suggest that the company is taking longer to pay its suppliers, possibly signaling liquidity issues or inefficiencies in the supply chain.
In conclusion, without the necessary data points, a detailed analysis of Collegium Pharmaceutical Inc's payables turnover ratio cannot be provided at this time.
Peer comparison
Dec 31, 2024